FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,123 | -86.5% | 3,360 | -50.0% | 0.00% | -100.0% |
| Q2 2023 | $52,652 | +43.6% | 6,720 | +100.0% | 0.00% | -50.0% |
| Q1 2023 | $36,658 | +83213.6% | 3,360 | -14.1% | 0.00% | +100.0% |
| Q4 2022 | $44 | -99.9% | 3,913 | +1.0% | 0.00% | 0.0% |
| Q3 2022 | $43,000 | 0.0% | 3,876 | +0.9% | 0.00% | 0.0% |
| Q2 2022 | $43,000 | -14.0% | 3,842 | -14.8% | 0.00% | 0.0% |
| Q1 2022 | $50,000 | – | 4,507 | – | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q1 2021 | $12,000 | – | 150 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 20 | -99.9% | 0.00% | -100.0% |
| Q4 2018 | $302,000 | -25.8% | 24,958 | -0.1% | 0.02% | +11.8% |
| Q3 2018 | $407,000 | -11.3% | 24,974 | -38.3% | 0.02% | -15.0% |
| Q2 2018 | $459,000 | +678.0% | 40,500 | +321.9% | 0.02% | +566.7% |
| Q1 2018 | $59,000 | 0.0% | 9,600 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $59,000 | +168.2% | 9,600 | +71.4% | 0.00% | +200.0% |
| Q3 2017 | $22,000 | +29.4% | 5,600 | +9.8% | 0.00% | 0.0% |
| Q2 2017 | $17,000 | -32.0% | 5,100 | -5.6% | 0.00% | 0.0% |
| Q1 2017 | $25,000 | -16.7% | 5,400 | -55.1% | 0.00% | 0.0% |
| Q4 2016 | $30,000 | +57.9% | 12,040 | +94.2% | 0.00% | 0.0% |
| Q3 2016 | $19,000 | +111.1% | 6,200 | +19.2% | 0.00% | 0.0% |
| Q2 2016 | $9,000 | -50.0% | 5,200 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $18,000 | – | 5,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |